Elias Traboulsi

Last updated

Elias I. Traboulsi (born May 19, 1957) is a physician in the fields of ophthalmic genetics and pediatric ophthalmology.

Contents

Early life

Elias Traboulsi was born May 19, 1957, in Beirut, Lebanon, to Iskandar and Renée Traboulsi. Dr. Traboulsi earned a bachelor's degree in Science in 1977 and a Doctorate in Medicine in 1982 at the American University of Beirut.

Professional career

Traboulsi completed a residency in ophthalmology at the American University of Beirut Medical Center in 1985. He then moved to the United States, to complete a fellowship in ophthalmic genetics at the Wilmer Ophthalmological Institute of Johns Hopkins Hospital, Baltimore, Maryland. Traboulsi continued his training with a residency in ophthalmology at Georgetown University Medical Center and a fellowship in pediatric ophthalmology and strabismus at Children's National Medical Center, both in Washington, D.C.

Positions

Following a year as chief resident in ophthalmology at Georgetown University Medical Center, Traboulsi joined the faculty at The Johns Hopkins Hospital, where he served as associate professor of ophthalmology from 1990 to 1997. He additionally was named as chairman of the Department of Ophthalmology at Johns Hopkins Bayview Medical Center 1995–1997.

In 1997, Traboulsi left Johns Hopkins to join the faculty at, Cleveland Clinic, Cleveland, Ohio, as head of the Department of Pediatric Ophthalmology and Strabismus and director of the Center for Genetic Eye Diseases, where he has worked since. He was director of the Cole Eye Institute fellowship program in Pediatric Ophthalmology and Strabismus 1997–2009, and has been the Cole Eye Institute residency program director since 2001. He was appointed director of the Graduate Medical Education and vice-chairman of the Cleveland Clinic Education Institute in 2005.

Traboulsi has also been a professor of ophthalmology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University since 2006.

Additional positions include:

Awards

His honors include:

Scientific contributions and professional legacy

Traboulsi has authored the books Genetic Diseases of the Eye (Oxford Press, First Ed. 1999) and A Compendium of Inherited Disorders and the Eye (Oxford Press, 2005). He has worked as principal investigator on a number of studies focused on determination and description of the molecular genetics and clinical manifestations of ocular disorders.

Related Research Articles

<span class="mw-page-title-main">Ophthalmology</span> Field of medicine treating eye disorders

Ophthalmology is a clinical and surgical specialty within medicine that deals with the diagnosis and treatment of eye disorders. A former term is oculism.

Pediatric ophthalmology is a sub-speciality of ophthalmology concerned with eye diseases, visual development, and vision care in children.

An eye care professional is an individual who provides a service related to the eyes or vision. It is any healthcare worker involved in eye care, from one with a small amount of post-secondary training to practitioners with a doctoral level of education.

Marshall Miller Parks was an American ophthalmologist known to many as "the father of pediatric ophthalmology".

<span class="mw-page-title-main">Axenfeld–Rieger syndrome</span> Medical condition

Axenfeld–Rieger syndrome is a rare autosomal dominant disorder, which affects the development of the teeth, eyes, and abdominal region.

The red reflex refers to the reddish-orange reflection of light from the back of the eye, or fundus, observed when using an ophthalmoscope or retinoscope. The reflex relies on the transparency of optical media and reflects off the fundus back through media into the aperture of the ophthalmoscope. The red reflex is considered abnormal if there is any asymmetry between the eyes, dark spots, or white reflex (Leukocoria).

Henry S. Metz is an American pediatric ophthalmologist. He was the CEO of the Smith-Kettlewell Institute in San Francisco from 2003 to 2008. Much of his early research concerned eye movements and strabismus, including saccadic velocity measurements and use of botulinum toxin.

<span class="mw-page-title-main">New York Eye and Ear Infirmary</span> Hospital in New York, United States

New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America's first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.

Gene Folk was an American ophthalmologist who specialized in the diagnosis and treatment of strabismus. A charter member of the American Association for Pediatric Ophthalmology and Strabismus, he later served as President of this organization. With Martin Urist, Folk helped found the "Chicago" school of strabismus, whose ideas competed with and stimulated those of Marshall M. Parks, Arthur Jampolsky, and other prominent strabismologists. During the 1950s and 1960s, Urist and Knapp's contributions led to a much improved understanding of so-called A and V "pattern" strabismus, where the amplitude of deviation varies in up- and downgaze.

Burt Kushner is an American pediatric ophthalmologist specializing in the diagnosis and treatment of strabismus. Kushner's contributions include demonstration of improved visual fields of patients following strabismus surgery, elucidation of torsional contribution to patients with diplopia, corticosteroid treatment of periocular capillary hemangioma, and novel hypotheses on the mechanism of "overacting" extraocular muscles.

Zeynel A. Karcioglu is a medical and surgical practitioner, researcher and medical educator. He is a diplomate of the American Board of Ophthalmology, specializing in Ophthalmic Oncology and Pathology particularly in areas of retinoblastoma, external eye tumors, and primary and metastatic orbital neoplasms. Karcioglu is also residency and fellowship trained in Anatomic Pathology and Neuropathology and certified by the American Board of Pathology.

Jane Kivlin is an American ophthalmologist who specializes in the diagnosis and treatment of pediatrics genetics and strabismus. A longstanding member of the American Association for Pediatric Ophthalmology and Strabismus, she served as President of this organization. She is well known for her contributions to the understanding of amblyopia and the ophthalmologic manifestations of shaken baby syndrome.

Marilyn T. Miller was an American pediatric ophthalmologist specializing in the diagnosis and treatment of congenital eye diseases and strabismus. She held leadership positions in her field.

<span class="mw-page-title-main">Persistent fetal vasculature</span> Medical condition

Persistent fetal vasculature(PFV), also known as persistent fetal vasculature syndrome (PFVS), and until 1997 known primarily as persistent hyperplastic primary vitreous (PHPV), is a rare congenital anomaly which occurs when blood vessels within the developing eye, known as the embryonic hyaloid vasculature network, fail to regress as they normally would in-utero after the eye is fully developed. Defects which arise from this lack of vascular regression are diverse; as a result, the presentation, symptoms, and prognosis of affected patients vary widely, ranging from clinical insignificance to irreversible blindness. The underlying structural causes of PFV are considered to be relatively common, and the vast majority of cases do not warrant additional intervention. When symptoms do manifest, however, they are often significant, causing detrimental and irreversible visual impairment. Persistent fetal vasculature heightens the lifelong risk of glaucoma, cataracts, intraocular hemorrhages, and Retinal detachments, accounting for the visual loss of nearly 5% of the blind community in the developed world. In diagnosed cases of PFV, approximately 90% of patients with a unilateral disease have associated poor vision in the affected eye.

The Filatov Institute is a research institute and a large ophthalmology (eye) hospital in Odesa, Ukraine. It was founded by Vladimir Filatov, an academic ophthalmologist. Its mission is the study of eye diseases and injuries, the training of ophthalmologists and the provision of eye care in Ukraine. The institute has 700 staff including 27 professors.

Terri L. Young is an American pediatric ophthalmologist.

Anil Kumar Mandal is an Indian ophthalmologist and a consultant at L. V. Prasad Eye Institute, Hyderabad. Known for his research on glaucoma, Mandal is an elected fellow of the National Academy of Medical Sciences. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, for his contributions to Medical Sciences in 2003.

Santosh Gajanan Honavar is an Indian ophthalmologist and is currently the Honorary General Secretary of the All India Ophthalmological Society; Director of Medical Services ; Director, Department of Ocular Oncology and Oculoplasty at Centre for Sight, Hyderabad; and Director, National Retinoblastoma Foundation. He was the Editor of the Indian Journal of Ophthalmology and Indian Journal of Ophthalmology - Case Reports, the official journals of the All India Ophthalmological Society from 2017 to 2023.

Alan Brown Scott was an American ophthalmologist specializing in eye muscles and their disorders, such as strabismus. He is best known for his work in developing and manufacturing the drug that became known as Botox, research described as "groundbreaking" by the ASCRS.

<span class="mw-page-title-main">Congenital blindness</span>

Congenital blindness refers to blindness present at birth. Congenital blindness is sometimes used interchangeably with "Childhood Blindness." However, current literature has various definitions of both terms. Childhood blindness encompasses multiple diseases and conditions present in ages up to 16 years old, which can result in permanent blindness or severe visual impairment over time. Congenital blindness is a hereditary disease and can be treated by gene therapy. Visual loss in children or infants can occur either at the prenatal stage or postnatal stage. There are multiple possible causes of congenital blindness. In general, 60% of congenital blindness cases are contributed from prenatal stage and 40% are contributed from inherited disease. However, most of the congenital blindness cases show that it can be avoidable or preventable with early treatment.

References